FindTrial
Sign In

Comparison of effectiveness between dry needling with and without needle retention in myofascial trigger point in upper trapezius muscle: Randomized, controlled, assessor-blind clinical trial

Comparison of effectiveness between dry needling with and without needle retention in myofascial trigger point in upper trapezius muscle: Randomized, controlled, assessor-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200126001
Enrollment
54
Registered
2020-01-26
Start date
2020-02-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain syndrome with myofascial trigger point in upper trapezius muscle Myofascial trigger point upper trapezius muscle dry needling needle retention

Interventions

A study group or DN with retention group got DN with needle retention for 30 minutes. DN procedure was performed by only one physician (Saesim A.) using a 0.25 x 25 mm acupuncture needle (Maanshan Bo
Ltd. China). The participants were treated in a prone position. A treatment area was firstly disinfected by a 70% alcohol. Then an acupuncture needle was inserted at the TrPs of upper trapezius muscle
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Dry needling with needle retention 30 minutes,Dry needling without needle retention

Sponsors

Faculty of Medicine, Prince of Songkla University
Lead Sponsor
์N/A
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: &#45; Age between 18 and 70 years &#45; Neck and/or shoulder pain for > 72 hours and < 1 year &#45; Most painful active MTrPs at upper trapezius muscle &#45; Pain of at least 40 mm on a visual analogue scale (VAS)

Exclusion criteria

Exclusion criteria: &#45; A history of fibromyalgia syndrome&#44; Whiplash injury&#44; cervical spine surgery and fracture&#44; cervical radiculopathy &#45; Having MTrPs therapy within the past month before the study &#45; Systemic disease such as rheumatism&#44; tuberculosis&#44; cervical myelopathy&#44; or multiple sclerosis &#45; Contraindication for needling including local infection&#44; pregnancy&#44; taking anticoagulants (e.g. warfarin)

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS) Before treatment&#44; 7 and 14 days after treatment Visual analogue scale (VAS)—

Secondary

MeasureTime frame
Pressure pain threshold (PPT) Before treatment&#44; 7 and 14 days after treatment Pressure algometer,Patient satisfaction scale 7 and 14 days after treatment 5&#45;point Likert scale,Side effects 7 and 14 days after treatment patient log book,Pain control by paracetamol recorded by patients 7 and 14 days after treatment patient log book,Compliance of stretching exercises recorded by patients 7 and 14 days after treatment patient log book—

Contacts

Public ContactPhichamon Khanittanuphong
khanittanuphong.p@gmail.com081-9592698

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026